Krilogy Financial’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-200
| Closed | -$1K | – | 844 |
|
|
2017
Q4 | $1K | Hold |
200
| – | – | ﹤0.01% | 758 |
|
|
2017
Q3 | $1K | Hold |
200
| – | – | ﹤0.01% | 797 |
|
|
2017
Q2 | $1K | Buy |
200
+167
| +506% | +$835 | ﹤0.01% | 713 |
|
|
2017
Q1 | $0 | Hold |
33
| – | – | ﹤0.01% | 734 |
|
|
2016
Q4 | $0 | Hold |
33
| – | – | ﹤0.01% | 787 |
|
|
2016
Q3 | $0 | Hold |
33
| – | – | ﹤0.01% | 804 |
|
|
2016
Q2 | $0 | Hold |
33
| – | – | ﹤0.01% | 781 |
|
|
2016
Q1 | $1K | Buy |
+33
| New | +$1K | ﹤0.01% | 677 |
|
|
2015
Q4 | – | Sell |
-233
| Closed | -$4K | – | 632 |
|
|
2015
Q3 | $4K | Buy |
+233
| New | +$4K | ﹤0.01% | 503 |
|